Conversely, MK3 showed significant focal deletion across a set of more than 3000 tumors, or its expression is low/absent in cancer cell types, including small-cell lung cancers, neuro- and medulloblastomas [32]. The gene discussed is MAPKAPK3; the disease is medulloblastoma.